← Back to All Filings

Agilent ($A) Appoints New CFO with $4.15M Equity Grant Package

Low SignificanceOctober 27, 2025 at 4:33:33 PM EDT

AGILENT TECHNOLOGIES, INC.

$A8-KCIK: 0001090872

Subscribe to track A

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Agilent ($A) Appoints New CFO with $4.15M Equity Grant Package

Company: AGILENT TECHNOLOGIES, INC. (A) Form: 8-K | Filed: 2025-10-27 Significance: Low

Insider: Adam S. Elinoff Title: Senior Vice President and Chief Financial Officer | Relationship: Officer

Transaction: • Type: Grant • Shares: Not specified • Price: $0.00 (Grant) • Value: $4,150,000 (Equity Awards) • Owned After: Not specified

Key Insight: Agilent announced the appointment of Adam S. Elinoff as its new CFO, providing a standard new-hire compensation package including a one-time cash bonus and significant equity awards vesting over several years.

Market Context: The equity grant value of $4.15M represents approximately 0.01% of Agilent's $41.97B market cap, indicating this is not a financially material transaction for the company, but a significant leadership change.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: AGILENT TECHNOLOGIES, INC. (A)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Agilent has appointed a new Chief Financial Officer, Adam S. Elinoff, with a comprehensive new-hire compensation package including $4.15 million in target equity awards.
  • Market Impact: The appointment is a significant leadership event, but the associated equity grant is not a market-moving transaction due to its small size relative to the company's market capitalization.

Company Information

FieldValue
CompanyAGILENT TECHNOLOGIES, INC.
Ticker SymbolA
CIK0001090872
IndustryLaboratory Analytical Instruments

Insider Information

FieldValue
NameAdam S. Elinoff
CIKnull
Title/PositionSenior Vice President and Chief Financial Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type8-K
Transaction Date2025-11-18
Transaction CodeA
Security TypeRestricted Stock Units (RSUs) and Performance-based RSUs
Shares InvolvedNot specified
Price Per Sharenull
Total Value$4,150,000
Shares Owned AfterNot specified
Ownership Typenull

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$4,150,000
% of Market Cap0.0099%
Shares TransactedNot specified
% of Shares OutstandingNot applicable
Post-Transaction OwnershipNot specified
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a large-cap company with a market capitalization of $41.97 billion, this $4.15 million equity grant is a routine part of executive compensation and is financially immaterial.
  • Ownership Concentration: The filing does not specify the number of shares, so post-transaction ownership cannot be calculated. However, as a new-hire grant, it will represent a very small fraction of total shares outstanding.
  • Dilution Impact: The grant will result in minor dilution to existing shareholders over a multi-year vesting period. Given the size of the grant relative to the 283.5 million shares outstanding, the dilutive effect is negligible.
  • Transaction Significance: The significance lies in the strategic appointment of a new CFO, not the financial size of the compensation package. The grant aligns the new executive's interests with shareholders but is not an open-market purchase reflecting immediate sentiment.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The market typically views the appointment of a qualified CFO from a reputable company (Amgen) as a positive, but the news is unlikely to cause a significant price move. The compensation package is standard for this level of executive at a company of this size.

Volume & Sentiment

  • Expected Volume Impact: Minimal. This is a corporate governance announcement, not a market-moving trade.
  • Sentiment Indicator: Neutral. The filing confirms a stable transition in a key leadership role.

Investment Insights

Positive Market Indicators

  • Successful recruitment of an experienced financial executive for a critical role.
  • Long-term vesting schedules for equity awards align the new CFO's incentives with long-term shareholder value.

Risk Factors

  • No immediate risk factors are apparent from this filing. It represents a standard corporate governance procedure.

Key Takeaways

  1. Leadership Change: Agilent has secured a new CFO, Adam S. Elinoff, effective November 17, 2025, replacing the interim CFO.
  2. Compensation Structure: The compensation is heavily weighted towards long-term, performance-based equity, which is a positive governance signal.
  3. Immaterial Transaction: The total value of the equity awards is $4.15 million, which is insignificant (0.0099%) compared to Agilent's $41.97 billion market cap.

Additional Context

Transaction Notes

  • Timing: The equity grants are effective November 18, 2025, shortly after the new CFO's start date.
  • Special Circumstances: The compensation package includes a $800,000 one-time cash bonus and a mix of time-based RSUs and performance-based RSUs, which will vest over three to four years. This is a typical structure to attract top executive talent.
  • Market Environment: The filing provides stability to the company's financial leadership team.
Topics:#SECFiling#Agilent#StockA#Form8K#CFO#ExecutiveComp#CorporateGovernance#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.